Press Releases
Search
-
16 Jul 2020
Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biothe...
-
09 Jul 2020
Second-Quarter 2020 Business Performance Preannouncement
In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity endi...
-
29 Jun 2020
bioMérieux issues a €200 million Euro PP bond
Marcy l’Étoile (France) - June 29, 2020 – bioMérieux, a global leader in the field of in vitro diagnostics, announces that it has successfully issued today a €200 million Euro PP new debt with a top-t...
-
15 Jun 2020
BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the BIOFIRE® Respiratory Panel 2.1 plus (RP2.1plus) is CE marked. The BIOFIRE® Respiratory Panel 2.1 plus (RP2.1pl...
-
21 May 2020
CE marking of bioMérieux serology tests for SARS-CoV-2 on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people who have been exposed to SARS-Co...
-
19 May 2020
Information concerning 2019 dividend and the bioMérieux General Shareholders’ Meeting
The Board of Directors of bioMérieux met today and decided to hold the annual General Shareholders’ Meeting behind closed doors at the bioMérieux registered office on June 30, 2020. During this meetin...